Total raised
—
Stage
Pre-Funding
Founded
2023
Headcount
3
HQ
Tel Aviv-Yafo
Sector
Health Tech & Life Sciences
About
ViVac is a revolutionary viral vaccine platform that immunizes against all viral proteins by safely and precisely mimicking actual viral infections. The platform is designed to provide more robustness and long-lasting immunity than mRNA/DNA and traditional vaccines while maintaining cost-effective production and enabling scale to meet new viral threats.
ViVac was founded by two of the world’s leading experts in synthetic biology and nano drug delivery.
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrug Delivery
Technologies
BiologicalsGenes
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2B
Highlights
1 PatentsVerified
Tags
drug-deliveryvaccines-developmentvaccinespharmaceuticalsimmunology